curriculum vitae maría elena martínez, m.p.h., ph.d

CURRICULUM VITAE María Elena Martínez, M.P.H., Ph.D.

OFFICE ADDRESS: University of California, San Diego UC San Diego Moores Cancer Center 3855 Health Sciences Drive, #0901 La Jolla, CA 92093-0901 Telephone: 858-822-3638 Fax: 858-822-2399 E-mail: [email protected] HOME ADDRESS: 3127 Maple St. San Diego, CA 92104-5026 CHRONOLOGY OF EDUCATION 1994-1996 Post-doctoral Fellow, Department of Nutrition, Harvard School of Public Health, Boston, MA 1993-1994 Post-doctoral Fellow, Department of Gastrointestinal Oncology and Digestive Diseases, University of Texas M.D. Anderson Cancer Center, Houston, TX 1993 Ph.D., Epidemiology University of Texas-Houston Health Science Center School of Public Health, Houston, TX

Dissertation: “A case-control study of diet and colorectal adenomatous polyps” Advisor: R. Sue McPherson, Ph.D. Thesis supervisor: Richard R. Shekelle, Ph.D.

1987 M.P.H., Nutrition and Population Studies University of Texas-Houston Health Science Center School of Public Health, Houston, TX

Thesis: “Iron under-nutrition in childhood malignancy” Advisor: George Kerr, M.D. Thesis supervisor: Jan van Eys, M.D. 1980 B.S., Nutrition and Medical Dietetics University of Illinois at the Medical Center, Chicago, IL

María Elena Martínez, M.P.H., Ph.D.

Updated 07/2017

CHRONOLOGY OF EMPLOYMENT Academic Appointments: 2012-Present Professor, Family Medicine and Public Health, UC San Diego, La Jolla, CA 2012-Present Sam M. Walton Endowed Chair for Cancer Research 2012-Present Co-leader, Reducing Cancer Disparities Program, UC San Diego Moores Cancer Center, La

Jolla, CA 2014-Present Adjunct Professor, Graduate School of Public Health, Health and Human Services, San Diego

State University, San Diego, CA 2012-2015 Regional Epidemiologist, Cancer Registry of Greater California, Sacramento, CA 2007-2011 Director, Cancer Health Disparities Institute, Arizona Cancer Center, Tucson, AZ 2005-2011 Richard H. Hollen Professor of Cancer Prevention, Arizona Cancer Center, Tucson, AZ 2005-2011 Professor of Epidemiology (Tenured), Mel and Enid Zuckerman Arizona College of Public

Health and Arizona Cancer Center, University of Arizona, Tucson, AZ 2005-2011 Co-Leader, Cancer Prevention and Control Program, Arizona Cancer Center, University of

Arizona, Tucson, AZ 2004-2005 Professor of Epidemiology (NT), Mel and Enid Zuckerman Arizona College of Public Health and

Arizona Cancer Center, University of Arizona, Tucson, AZ 2004-2011 Professor of Nutrition (adjunct faculty), Nutrition Department, College of Agriculture and Life

Sciences, University of Arizona, Tucson, AZ 2004-2005 Associate Professor of Nutrition (adjunct faculty), Nutrition Department, College of Agriculture

and Life Sciences, University of Arizona, Tucson, AZ 2001-2005 Associate Professor of Epidemiology (NT), Mel and Enid Zuckerman Arizona College of Public

Health and Arizona Cancer Center, University of Arizona, Tucson, AZ 2001-2005 Associate Professor (appointed faculty), Mexican American Studies and Research Center,

College of Social and Behavioral Sciences, University of Arizona, Tucson, AZ 1996-2001 Research Assistant Professor of Epidemiology, College of Public Health and Arizona Cancer

Center, University of Arizona, Tucson, AZ 1999-2001 Research Assistant Professor (appointed faculty), Mexican American Studies and Research

Center, College of Social and Behavioral Sciences, University of Arizona, Tucson, AZ HONORS AND AWARDS: 2017 Service to the Profession Award, Center to Reduce Cancer Health Disparities, National Cancer

Institute, Bethesda, MD 2013 Women Who Mean Business Award, San Diego Business Journal, San Diego, CA 2010 Distinguished Alumnus Award, MD Anderson Cancer Center, Houston, TX 2007 Researcher of the Year Award, Mel and Enid Zuckerman College of Public Health 2007 Best Poster Award, American Society of Preventive Oncology Annual Meeting 1993 University of Texas School of Public Health Alumni Association Minority Scholarship 1992 University of Texas School of Public Health Alumni Association Minority Scholarship SERVICE/OUTREACH National/International Outreach Current 2017-Present American Association for Cancer Research, Distinguished Lectureship on the Science of

Cancer Health Disparities Selection Committee 2017-Present Fred Hutch/University of Washington Cancer Consortium, External Advisory Board 2016-Present National Cancer Institute, National Cancer Moonshot Initiative, Blue Ribbon Panel Member 2015-Present University of Michigan Comprehensive Cancer Center, External Advisory Board 2014-Present Cancer Prevention Research Institute of Texas, Study Section Review Member


Updated 07/2017

2014-Present Hollings Cancer Center, External Advisory Board 2013-Present Hispanic Community Health Study/Study of Latinos (HCHS/SOL), Genetic Studies Committee

Member 2013-Present American Society of Preventive Oncology, Director-at-Large 2010-Present National Cancer Institute, Board of Scientific Advisors 2011-Present Georgetown Lombardi Cancer Center, External Advisory Board 2011-Present Roswell Park Cancer Indirectstitute, External Advisory Board 2007-Present Latinas Contra el Cancer, National Latino Cancer Summit Conference Program member 2008-Present American Association for Cancer Research Minorities in Cancer Research Roundtable

Participant Completed 2016 Shaping the Future of Cancer Prevention: a Roadmap for Integrative Cancer Science and

Public Health. American Association for Cancer Research Cancer Prevention Summit. Summit Presenter. February 3-5, 2016. Lansdowne Resort, Leesburg, VA

2015 Towards Cancer Health Equity: Biology, Lifestyle, and Access Workshop. National Cancer Institute Think Tank. Presenter. November 11-12, 2015. Atlanta, GA.

2015 Understudied Populations in Cancer Epidemiologic Research: Implications on Future Needs. National Cancer Institute Workshop. September 8-9, 2015. Rockville, MD.

2014-2015 American Association for Cancer Research, Cancer Prevention Committee 2011-2016 Washington University in St. Louis, TREC Center, External Advisory Board 2010 How to Mentor and Be Mentored: Challenges and Opportunities for Minority Scientists.

Minorities in Cancer Research Form at AACR 101st Annual Meeting. Washington, D.C. 2009-2010 American Association for Cancer Research, Minorities in Cancer Research Council Chair 2009-2010 American Association for Cancer Research, Third Annual Science of Cancer Health Disparities,

Scientific Program Committee 2007-2011 H. pylori Eradication Trial in Latin America, Steering Committee Member 2009-2010 National Cancer Institute’s GMap/BMap Conference Committee 2008-2009 American Association for Cancer Research, Second Annual Science of Cancer Health

Disparities, Conference Co-Chair 2008 AACR Career Survival Forum for Young Investigators, San Antonio Breast Cancer Meeting 2008 American Association for Cancer Research Special Conference: Candidate Pathways, Whole

Genome Scans: Reconciling Results, Looking into the Future, Session Chairperson and Program Committee Member

2008 American Association for Cancer Research Minorities in Cancer Research Professional Advancement Roundtable Committee

2007-2014 H. pylori Trial in Latin America, Steering Committee Member 2007-2008 University of Puerto Rico Comprehensive Cancer Center, Population Sciences and Cancer

Control Program, Scientific Advisory Committee 2007 Fred Hutchinson Cancer Center, Public Health Services Division, External Advisory Committee 2007 Moores Cancer Center, University of California San Diego, External Advisory Committee 2007 American Association for Cancer Research, Sixth Annual International Conference on Frontiers in Cancer Prevention Research, Scientific Review Committee 2007 American Association for Cancer Research, The Science of Cancer Health Disparities

Conference, Program Committee 2007 American Society for Preventative Oncology, Program Planning Committee Member and

Session Chair 2006-2011 Cancer Research and Prevention Foundation Medical Advisory Board 2006-2008 R25 Cancer Prevention and Control Post-doctoral Fellowship Advisory Board, Nutrition

Department, Harvard School of Public Health 2006 Redes en Acción Network, Steering Committee Member


Updated 07/2017

2006-2011 Arizona Department of Health Services, Arizona Comprehensive Cancer Plan. Disparities Committee member.

2005-2011 Yerby Post-doctoral Fellowship Program (for under-represented minorities) Advisory Board, Harvard School of Public Health

2005-2006 American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Prevention Committee

2005 Chair, Epidemiology of Cancer Study Section (EPIC) Member Conflicts, National Institutes of Health, Bethesda, MD

2005 AACR Frontiers in Cancer Prevention Scientific Program Committee 2005 Moving from Observational Studies to Clinical Trials: Why do we Sometimes Get it Wrong?

National Institutes of Health Conference, Bethesda, MD 2004-2010 National Cancer Institute, Board of Scientific Counselors, Clinical Sciences and Epidemiology 2004-2007 American Society for Preventive Oncology. Program Committee. 2004-2006 American Association for Cancer Research Minority Scholar Awards in Cancer Research

Program Committee Member 2004-2006 American Association for Cancer Research, Cancer Prevention Awards Committee Member 2004-2005 Oncogenomics 2005: Dissecting Cancer through Genome Research. Program Committee 2004 Participant, National Cancer Institute’s Minority Investigator Career Development Workshop 2003-2011 U54 MD Anderson Cancer Center/University of Puerto Rico Partnership for Excellence in

Cancer Research, Program Steering Committee 2003-2004 Scientific Reviewer, European Commission's 6th Framework Programme for Research and

Demonstration Activities 2003 National Cancer Institute’s Minority Mentoring Planning Meeting, Advisory Committee Member 2002-2003 AACR Frontiers in Cancer Prevention Program Planning Committee 2001-2005 Scientific Reviewer for Epidemiology of Cancer (EPIC) Study Section, National Institutes of

Health, Bethesda, MD 2001 Member, American Cancer Society’s Nutrition and Physical Activity Guidelines Advisory

Committee 1999-2000 Member, Colorectal Cancer Progress Review Group (Environment and Lifestyle Group Co-

chair), National Cancer Institute, National Institutes of Health, Bethesda, MD Editorial Boards: 2009-Present Senior Editor, Cancer Epidemiology, Biomarkers and Prevention (Cancer Disparities Section) 2000-Present Associate Editor, Journal of the National Cancer Institute 2008-2009 Associate Editor, Cancer Epidemiology, Biomarkers and Prevention 2003-2005 Senior Editor, Cancer Epidemiology, Biomarkers and Prevention 2002-2006 Editorial Board, Cancer Spectrum 1998-2002 Associate Editor, Cancer Epidemiology, Biomarkers and Prevention Manuscript Reviewer: American Journal of Epidemiology American Journal of Gastroenterology Archives of Internal Medicine Cancer Causes and Control Cancer Epidemiology, Biomarkers, and Prevention Cancer Research Carcinogenesis Epidemiology International Journal of Cancer International Journal of Epidemiology Gastroenterology Journal of the American Medical Association Journal of Health Care for the Poor and Underserved


Updated 07/2017

Journal of Preventive Medicine Journal of the National Cancer Institute Journal of Women’s Health New England Journal of Medicine Society Memberships: American Association for Cancer Research American Society of Preventive Oncology World Endoscopy Organization Council of the International Digestive Cancer Alliance Society for Epidemiologic Research University Committees University of California San Diego 2017-Present School of Public Health Planning Committee 2017-Present Master in Public Health Planning Committee 2017-Present Mentoring Workshop Committee 2016-Present Academic Senate, San Diego Division, Primary Representative. 2014-2016 Academic Senate, San Diego Division, Alternate Representative. 2015-2016 Moores Cancer Center Family Medicine and Public Health Leadership Search Committee 2014-Present Health Sciences Faculty Equity Committee 2013-2015 Family and Preventive Medicine Health Disparities Search Committee 2012-2013 Family and Preventive Medicine Global Health Faculty Search Committee Chair 2012-2013 Center for Academic Research and Training in Anthropogeny (CARTA) ORU Five-year Review

Committee 2012 Family and Preventive Medicine Research Retreat Committee 2012-Present FMPH Health Behavior Change in Underserved and Vulnerable Populations Center of

Excellence member Moores Cancer Center 2017-Present Associate Director, Population Sciences, Disparities, and Community Engagement 2017-Present Executive Committee Member 2015-Present Primary Liver Cancer Task Force 2013-Present Senior Leaders Council Member 2013-Present Clinical Research Practice Committee Member 2013-Present Colorectal Disease Team Committee Member 2012-Present Co-leader, Reducing Cancer Disparities Program University of Arizona Committees 2009-2011 Promotion and Tenure Committee, University of Arizona 2004-2006 Faculty Mentor, Initiative for Minority Student Development, Graduate College, University of

Arizona 2003-2006 Clinical Research Curriculum Award Advisory Board Member. College of Medicine, University

of Arizona 2000-2011 Faculty Mentor, McNair Achievement Program, Graduate College, University of Arizona Mel and Enid Zuckerman College of Public Health 2010-2011 Epidemiology Faculty Search Committee 2007-2008 Dean’s Search Committee 2006-2009 Promotion and Tenure Review Committee 2005-2006 Administrative Review of Dean G. Marie Swanson Committee 2004-2007 Division of Epidemiology and Biostatistics Peer Review Committee (chair)


Updated 07/2017

2002-2003 Biostatistics Faculty Search Committee 2000-2011 Epidemiology Program, Admissions Committee 2000-2006 Epidemiology Program, Executive Committee Arizona Cancer Center 2006-2011 U54 Native American Partnership for Native American Cancer Partnership Program, Internal

Advisory Board Committee Member. 2007-2011 Co-director and Founder, Cancer Health Disparities Institute. 2007-2011 American Cancer Society/Internal Cancer Research Grants Review Committee 2005-2011 Director’s Committee 2004-2011 Member, Cancer Biology Graduate Interdisciplinary Program 2007-2009 Arizona Cancer Center/University of New Mexico Cancer Center Partnership Committee, Chair 2003-2004 Arizona Cancer Center Director Search Committee 2003-2008 Space Committee 2003-2005 Better than Ever Small Grants Review Committee 2003-2011 American Cancer Society Small Grants Reviewer 2002-2003 Cabinet Member (Alternate to David Alberts) 2002-2005 Sunstone Scientific Advisory Board Member 2002-2006 Head of Epidemiology in the Cancer Prevention and Control Program 2002-2011 Member, R25 Cancer Prevention and Control Advisory Board 2002-2009 Member, GI SPORE Executive Committee 2002-2011 Endpoints Review Committee Co-director, Colon Cancer Prevention Program Project 2001-2011 Director of Data Management, Colon Cancer Prevention Program Project PUBLICATIONS/CREATIVE ACTIVITY (PUBLISHED OR IN PRESS) Peer-reviewed Manuscripts 1. Perez LG, Elder JP, Haughton J, Martínez ME, Arredondo EM. Socio-demographic Moderators of

Associations Between Psychological Factors and Latinas’ Breast Cancer Screening Behaviors. J Immigr Minor Health. 2017 Jul 27; doi: 10.1007/s10903-017-0633-1. [Epub ahead of print] PMID: 28752364.

2. Martínez ME, Gomez, SL, Tao L, Cress R, Rodriguez D, Unkart J, Schwab R, Nodora JN, Cook L, Komenaka I, Li C. Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic white women. Breast Cancer Res Treat. 2017 Jul 11; doi: 10.1007/s10549-017-4389-z. [Epub ahead of print] PMID: 28698973.

3. Martínez ME, Unkart JT, Tao L, Kroenke CH, Schwab R, Komenaka I, Gomez SL. Prognostic significance of marital status in breast cancer survival: A population-based study. PLoS One. 2017 May 5;12(5):e0175515. doi: 10.1371/journal.pone.0175515. eCollection 2017. PMID: 28475579.

4. Eubanks RD, Nodora JN, Hsu CH, Bagley M, Bouton ME, Martinez ME, Komenaka IK. The Feasibility and Time Required for Routine Health Literacy Assessment in Surgical Practice and Effect on Patient Satisfaction. Am Surg. 2017 May 1;83(5):458-464. PMID: 28541854.

5. Jabo B, Morgan JW, Martinez ME, Ghamsary M, Wieduwilt MJ. Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients. PLoS One. 2017 Apr 6;12(4):e0174760. doi: 10.1371/journal.pone.0174760. eCollection 2017. PMID: 28384176.

6. Elder JP, Haughton J, Perez LG, Martínez ME, De la Torre CL, Slymen DJ, Arredondo EM. Health Educ Res. 2017 Apr 1;32(2):163-173. doi: 10.1093/her/cyx033. PMID: 28380627.

7. Gupta S, Jacobs ET, Baron JA, Lieberman DA, Murphy G, Ladabaum U, Cross AJ, Jover R, Liu L, Martinez ME. Risk stratification of individuals with low-risk colorectal adenomas using clinical characteristics: a pooled analysis. Gut. 2017 Mar 11;66(3):446-453. doi: 10.1136/gutjnl-2015-310196. Epub 2015 Dec 11. PMID: 26658145.


Updated 07/2017

8. Bryant AK, Banegas M, Martinez ME, Mell LK, Murphy JD. Trends in radiation therapy among cancer survivors in the United States, 2000-2030. Cancer Epidemiol Biomarkers Prev. 2017 Jan 17. pii: cebp.1023.2016. doi: 10.1158/1055-9965.EPI-16-1023 [Epub ahead of print]. PMID: 28096199.

9. Heberer MA, Komenaka IK, Nodora JN, Hsu CH, Gandhi SG, Welch LE, Bouton ME, Aristizabal P, Weiss BD, Martinez ME. Factors associated with cervical cancer screening in a safety new population. World J Clin Oncol. 2016 Oct 10;7(5):406-413. doi: 10.5306/wjco.v7.i5.406. PMID: 27777883. PMCID PMC5056332.

10. Liu L, Messer K, Baron JA, Lieberman DA, Jacobs ET, Cross AJ, Murphy G, Martinez ME, Gupta S. A prognostic model for advanced colorectal neoplasia recurrence. Cancer Causes Control. 2016 Oct;27(10):1175-85. doi: 10.1007/s10552-016-0795-5. Epub 2016 Aug 12. PMID: 27517467.

11. Nodora JN, Komenaka IK, Bouton ME, Ohno-Machado L, Schwab R, Kim H, Farcas C, Perez G, Martínez ME. Biospecimen Sharing Among Hispanic Women in a Safety-Net Clinic: Implications for the Precision Medicine Initiative. J Natl Cancer Inst. 2016 Sep 28;109(2) pii: djw201. doi: 10.1093/jnci/djw201. Print 2017 Feb. PMID: 27688295.

12. Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F, Bhattacharyya A, Hsu CH, Chow HH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Hamilton SR, Jacobs ET, Martinez ME, Alberts DS, Lance P. Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes. J Natl Cancer Inst. 2016 Aug 16;108(12). pii: djw152. doi: 10.1093/jnci/djw152. Print 2016 Dec. PMID: 27530657

13. Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F, Bhattacharyya A, Hsu CH, Chow SH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Hamilton SR, Jacobs ET, Martinez EM, Alberts DS, Lance P. Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial. J Natl Cancer Inst. 2016 Aug 16;108(12). pii: djw151. doi: 10.1093/jdifnci/djw151. Print 2016 Dec. PMID: 27530656

14. Martínez ME, Anderson K, Murphy JD, Hurley S, Canchola AJ, Keegan TH, Cheng I, Clarke CA, Glaser SL, Gomez SL. Differences in marital status and mortality by race/ethnicity and nativity among California cancer patients. Cancer. 2016 May 15;122(10):1570-8. doi: 10.1002/cncr.29886. PMID: 27065455. PMCID: PMC5523959

15. Gomez SL, Hurley S, Canchola AJ, Keegan THM, Cheng I, Murphy JD, Clarke CA, Glaser SL, Martinez ME. Effects of marital status and economic resources on survival after cancer: A population-based study. Cancer. 2016 May 15;122(10):1618-25. doi: 10.1002/cncr.29885. PMID: 27065317. PMCID: PMC5558592.

16. Jacobs ET, Haussler MR, Alberts DS, Kohler LN, Lance P, Martinez ME, Roe DJ, Jurutka PW. Association between circulating vitamin D metabolites and fecal bile acid concentrations. Cancer Prev Res. 2016 May 2. pii: canprevres.0033.2016 [Epub ahead of print] PMID: 27138789

17. Martin DN, Lam TK, Brignole K, Ashing KT, Bolt WJ, Burhansstipanov L, Chen JT, Dignan M, Gomez SL, Martinez ME, Matthews A, Palmer JR, Perez-Stable EJ, Schootman M, Vilchis H, Vu A, Srinivasan S. Recommendations for Cancer Epidemiologic Research in Understudied Populations and Implications for Future Needs. Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):573-80. doi: 10.1158/1055-9965.EPI-15-1297. PMID: 7196089.

18. Figueroa JD, Middlebrooks CD, Banday AR, Ye Y, Garcia-Closas M, Chatterjee N, Koutros S, Kiemeney LA, Rafnar T, Bishop T, Furberg H, Matullo G, Golka K, Gago-Dominguez M, Taylor JA, Fletcher T, Siddiq A, Cortessis VK, Kooperberg C, Cussenot O, Benhamou S, Prescott J, Porru S, Dinney CP, Malats N, Baris D, Purdue MP, Jacobs EJ, Albanes D, Wang Z, Chung CC, Vermeulen SH, Aben KK, Galesloot TE, Thorleifsson G, Sulem P, Stefansson K, Kiltie AE, Harland M, Teo M, Offit K, Vijai J, Bajorin D, Kopp R, Fiorito G, Guarrera S, Sacerdote C, Selinski S, Hengstler JG, Gerullis H, Ovsiannikov D, Blaszkewicz M, Castelao JE, Calaza M, Martinez ME, et al. Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry. Hum Mol Genet. 2016 Mar 15;25(6):1203-14. doi: 10.1093/hmg/ddv492. Epub 2016 Jan 4. PMID: 26732427

19. Gago-Dominguez M, Castelao JE, Gude F, Fernandez MP, Aguado-Barrera ME, Ponte SM, Redondo CM, Castelo ME, Dominguez AN, Garzón VM, Carracedo A, Martínez ME. Alcohol and breast cancer

http://www.ncbi.nlm.nih.gov/pubmed/?term=Martinez%20ME%5BAuthor%5D&cauthor=true&cauthor_uid=26690931




Updated 07/2017

tumor subtypes in a Spanish Cohort. Springerplus. 2016 Jan 15;5:39. doi: 10.1186/s40064-015-1630-2. eCollection 2016. PMID: 6835221.

20. Komenaka IK, Nodora JN, Madlensky L, Winton LM, Heberer MA, Schwab RB, Weitzel JN, Martinez ME. Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety-net institution. J Community Genet. 2016 Jul;7(3):177-83. doi: 10.1007/s12687-015-0257-x PMID: 26690931.

21. Winton LM, Nodora JN, Martinez ME, Hsu CH, Djenic B, Bouton ME, Aristizabal P, Ferguson EM, Weiss BD, Komenaka IK. Factors associated with surgical management in an underinsured, safety net population. Surgery. 2015 Oct 3. pii: S0039-6060(15)00655-8. doi: 10.1016/j.surg.2015.08.016. PMID: 26444326.

22. Nodora JN, Cooper R, Talavera GA, Gallo L, Meza Montenegro MM, Komenaka I, Natarajan L, Gutiérrez Millán LE, Daneri-Navarro A, Bondy M, Brewster A, Thompson P, Martinez ME. Acculturation, Behavioral Factors, and Family History of Breast Cancer among Mexican and Mexican-American Women. Womens Health Issues. 2015 Sep-Oct;25(5):494-500. doi: 10.1016/j.whi.2015.05.011. Epub 2015 Jul 17. PMID: 26189937.

23. Goebel M, Singal AG, Nodora J, Castañeda SF, Martinez ME, Doubeni C, Laiyemo A, Gupta S. How can we boost colorectal and hepatocellular cancer screening among underserved populations ? Current Gastroenterology Reports. 2015;17(6) :445. doi : 10.1007/s11894-015-0445-1. PubMed PMID: 26031831.

24. Murphy JD, Ma GL, Baumgartner JM, Madlensky L, Burgoyne AM, Tang CM, Martinez ME, Sicklick JK. Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study. Cancer. 2015 Sep 1;121(17):2960-7. doi: 10.1002/cncr.29434. PMID: 25930983.

25. Muñoz-Rodriguez JL, Vrba L, Futscher BW, Hu C, Komenaka IK, Meza-Montenegro MM, Gutierrez-Millan LE, Daneri-Navarro A, Thompson PA, Martinez ME. Differentially Expressed MicroRNAs in Postpartum Breast Cancer in Hispanic Women. PLoS One. 2015Apr 13; 10(4):e0124340. PMID: 25875827.

26. Patterson RE, Laughlin GA, Sears DD, LaCroix AZ, Marinac C, Gallo LC, Hartman SJ, Natarajan L, Senger CM, Martínez ME, Villaseñor A. Intermittent Fasting and Human Metabolic Health. J Acad Nutr Diet. 2015 Aug;115(8):1203-12. doi: 10.1016/j.jand.2015.02.018. PMID: 25857868.

27. Komenaka IK, Nodora JN, Hsu CH, Martinez ME, Gandhi SG, Bouton ME, Klemens AE, Wikholm LI, Weiss BD. Association of health literacy with adherence to screening mammography guidelines. Obstet Gynecol. 2015 Apr; 125(4):852-9. PMID: 25751204.

28. Aristizabal P, Singer J, Cooper R, Wells KJ, Nodora J, Milburn M, Gahagan S, Schiff DE, Martinez ME. Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities. Pediatr Blood Cancer. 2015 Aug;62(8):1337-44. doi: 10.1002/pbc.25472. PMID: 25755225.

29. Anderson K, Thompson PA, Wertheim BC, Martin L, Komenaka IK, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Brewster A, Madlensky L, Tobias M, Natarajan L, Martinez ME. Family History of Breast and Ovarian Cancer and Triple Negative Subtype in Hispanic/Latina Women. Springerplus. 2014 Dec 11;3:727. doi: 10.1186/2193-1801-3-727. eCollection 2014. PMID: 25713754.

30. Bea JW, Jurutka PW, HIbler EA, Lance P, Martinez ME, Roe DJ, Sardo Molmenti CL, Thompson PA, Jacobs ET. Concentrations of the Vitamin D Metabolite 1,25(OH)2D and Odds of Metabolic Syndrome and its Components. Metabolism. 2015 Mar;64(3):447-59. PMID: 25496802.

31. Komenaka IK, Winton LM, Bouton ME, Hsu CH, Nodora JN, Olson L, Maffi TR, Nesset EM, Martinez ME. Women’s Impression of the expected breast appearance and its association with breast cancer operations. Ann Surg Oncol 2015;22(6):2010-6. doi: 10.1245/s10434-014-4233-1. PMID: 25398279.

32. Ma GL, Murphy JD, Martinez ME, Sicklick JK. Epidemiology of Gastrointestinal Stromal Tumors in the Era of Histology Codes: Results of a Population-Based Study. Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):298-302. doi: 10.1158/1055-9965.EPI-14-1002. PMID: 25277795.

33. Olsen-Deeter L, Hsu CH, Nodora JN, Bouton ME, Nalagan J, Martinez ME, Komenaka IK. Factors which affect use of breast conservation and mastectomy in an underinsured Hispanic population. Surg Oncol 2014 Sep22;23(4): 186-1691. PMID: 25443563.

http://www.ncbi.nlm.nih.gov/pubmed/?term=Komenaka%20IK%5BAuthor%5D&cauthor=true&cauthor_uid=26690931

http://www.ncbi.nlm.nih.gov/pubmed/?term=Nodora%20JN%5BAuthor%5D&cauthor=true&cauthor_uid=26690931

http://www.ncbi.nlm.nih.gov/pubmed/?term=Madlensky%20L%5BAuthor%5D&cauthor=true&cauthor_uid=26690931

http://www.ncbi.nlm.nih.gov/pubmed/?term=Winton%20LM%5BAuthor%5D&cauthor=true&cauthor_uid=26690931

http://www.ncbi.nlm.nih.gov/pubmed/?term=Heberer%20MA%5BAuthor%5D&cauthor=true&cauthor_uid=26690931

http://www.ncbi.nlm.nih.gov/pubmed/?term=Schwab%20RB%5BAuthor%5D&cauthor=true&cauthor_uid=26690931

http://www.ncbi.nlm.nih.gov/pubmed/?term=Weitzel%20JN%5BAuthor%5D&cauthor=true&cauthor_uid=26690931



http://www.ncbi.nlm.nih.gov/pubmed/?term=Aristizabal%20P%5BAuthor%5D&cauthor=true&cauthor_uid=25755225

http://www.ncbi.nlm.nih.gov/pubmed/?term=Singer%20J%5BAuthor%5D&cauthor=true&cauthor_uid=25755225

http://www.ncbi.nlm.nih.gov/pubmed/?term=Cooper%20R%5BAuthor%5D&cauthor=true&cauthor_uid=25755225

http://www.ncbi.nlm.nih.gov/pubmed/?term=Wells%20KJ%5BAuthor%5D&cauthor=true&cauthor_uid=25755225

http://www.ncbi.nlm.nih.gov/pubmed/?term=Nodora%20J%5BAuthor%5D&cauthor=true&cauthor_uid=25755225

http://www.ncbi.nlm.nih.gov/pubmed/?term=Milburn%20M%5BAuthor%5D&cauthor=true&cauthor_uid=25755225

http://www.ncbi.nlm.nih.gov/pubmed/?term=Gahagan%20S%5BAuthor%5D&cauthor=true&cauthor_uid=25755225

http://www.ncbi.nlm.nih.gov/pubmed/?term=Schiff%20DE%5BAuthor%5D&cauthor=true&cauthor_uid=25755225



Updated 07/2017

34. Wong J, Xu B, Yeung HN, Roeland EJ, Martinez ME, Le QT, Mell LK, Murphy JD. Age disparity in palliative radiation therapy among patients with advanced cancer. Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):224-30. PMID: 25195994.

35. Sardo Molmenti CL, Hibler EA, Ashbeck EL, Thomson CA, Garcia DO, Roe D, Harris RB, Lance P, Cisneroz M, Martinez ME, Thompson PA, Jacobs ET. Sedentary behavior is associated with colorectal adenoma recurrence in men. Cancer Causes Control. 2014 Oct;25(10): 1387-95. Jul 25 PMID: 25060482. PMCID PMC4228938.

36. Nodora JN, Gallo L, Cooper R, Wertheim BC, Natarajan L, Thompson PA, Komenaka IK, Brewster A, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Martinez ME. Reproductive and hormonal risk profile according to language acculturation and country of residence in the Ella binational breast cancer study. J Womens Health. 2014;23(6):532-40. PMID: 24475760.

37. Komenaka IK, Nodora JN, Machado L, Hsu CH, Klemens AE, Martinez ME, Bouton ME, Wilhelmson KL, Weiss BD. Health literacy assessment and patient satisfaction in surgical practice. Surgery. 2014;155(3):374-83. PMID: 24485272.

38. Gupta S, Sussman DA, Doubeni CA, Anderson DS, Day L, Deshpande AR, Elmunzer BJ, Laiyemo AO, Mendez J, Somsouk M, Allison J, Bhuket T, Geng Z, Green BB, Itzkowitz SH, Martinez ME. Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst. 2014;106(4):dju032. PMCID PMC3982886.

39. Nodora JN, Carvajal SC, Robles-Garcia R, Agraz FP, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Martinez ME. Development and Psychometric Assessment of the Measure of Globalization Influence on Health Risk (MGIHR) Among Mexican Women with Breast Cancer. J Immigr Minor Health. 2015 Aug;17(4):1025-32. doi: 10.1007/s10903-014-0042-7. PMID: 24859806.

40. Anderson KN, Schwab RB, Martinez ME. Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat. 2014;144(1):1-10. PMID: 24477977.

41. Thomson CA, McCullough ML, Wertheim BC, Chlebowski RT, Martinez ME, Stefanick ML, Rohan TE, Manson JE, Tindle HA, Ockene J, Vitolins MZ, Wactawski-Wende J, Sarto GE, Lane DS, Neuhouser ML. Nutrition and Physical Activity Cancer Prevention Guidelines, Cancer Risk, and Mortality in the Women’s Health Initiative. Cancer Prev Res. 2014;7(1):42-53. PMID: 24403289. PMCID PMC4090781.

42. Robertson DJ, Lieberman DA, Winawer SJ, Ahnen DJ, Baron JA, Schatzkin A, Cross AJ, Zauber AG, Church TR, Lance P, Greenberg ER, Martínez ME. Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut. 2014;63(6):949-56. PMID: 23793224.

43. Simpson DR, Martínez ME, Gupta S, Hattangadi-Gluth J, Mell LK, Heestand G, Fanta P, Ramamoorthy S, Le QT, Murphy JD. Racial Disparity in Consultation, Treatment, and the Impact on Survival in Metastatic Colorectal Cancer. J Natl Cancer Inst. 2013; 105(23):1814-20. PMID: 24231453.

44. Martinez ME, Wertheim BC, Natarajan L, Schwab R, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Brewster A, Komenaka I, Thompson P. Reproductive Factors, Heterogeneity, and Breast Tumor Subtypes in Women of Mexican Descent. Cancer Epidemiol Biomarkers Prev. 2013;22(10):1853-61. PMID: 23950213.

45. Morgan DR, Torres J, Sexton R, Herrero R, Salazar-Martinez E, Greenberg ER, Bravo LE, Dominguez RL, Ferreccio C, Lazcano-Ponce EC, Meza-Montenegro MM, Pena EM, Pena R, Correa P, Martinez ME, Chey WD, Valdivieso M, Anderson GL, Goodman GE, Crowley JJ, Baker LH. Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities. JAMA. 2013;309(6):578-86. PMID: 23403682.

46. Flores-Luna L, Camorlinga-Ponce M, Hernandez-Suarez G, Kasamatsu E, Martinez ME, Murillo R, Lazcano E, Torres J. The utility of serologic tests as biomarkers for Helicobactor pylori-associated precancerous lesions and gastric cancer varies between Latin American countries. Cancer Causes Control. 2013;24(2):241-8. PMID 23184121.

47. Thompson P, Roe DJ, Fales L, Buckmeier J, Wang F, Hamilton SR, Bhattacharyya A, Green S, Hsu CH, Chow HH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Martinez ME, Jacobs E, Ashbeck EL, Alberts DS, Lance P. Design and Baseline Characteristics of Participants in a Phase III Randomized Trial of Celecoxib and Selenium for Colorectal Adenoma Prevention. Cancer Prev Res. 2012;12(5):1381-93. PMCID PMC3518663.


Updated 07/2017

48. Martínez ME, Pond E, Wertheim BC, Nodora, JN, Jacobs ET, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Brewster A, Komenaka IK, Thompson P. Association between Parity and Obesity in Mexican and Mexican-American Women: Findings from the Ella Binational Breast Cancer Study. J Immigr Minor Health. 2013;15(2):234-43. PMCID PMC3469728.

49. Cruz GI, Martinez ME, Natarajan L, Wertheim BC, Gago-Dominguez M, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Brewster A, Schedin P, Komenaka IK, Castelao JE, Carracedo A, Redondo CM, Thompson PA. Hypothesized role of pregnancy hormones on HER2+ breast tumor development. Breast Cancer Res Treat. 2013;137(1):237-46. PMID: 23135573.

50. Martinez ME, Thompson P, Messer K, Ashbeck EL, Lieberman DA, Baron JA, Ahnen DJ, Robertson DJ, Jacobs ET, Greenberg ER, Cross AJ, Atkin W. One-year risk for advanced colorectal neoplasia: U.S. versus U.K. risk-stratification guidelines. Ann Intern Med. 2012;157(12):856-64. PMID: 23247939.

51. Beamer PI, Luik CE, Abrell L, Campos S, Martínez ME, Sáez E. Concentration of Trichloroethylene in Breast Milk and Household Water from Nogales, Arizona. Environ Sci Technol. 2012;6(16):9055-61. PMID: 22827160.

52. Redondo CM, Gago-Domínguez M, Ponte SM, Castelo ME, Jiang X, García AA, Fernández MP, Tomé MA, Fraga M, Gude F, Martínez ME, Garzón VM, Carracedo A, Castelao JE. Breast feeding, parity and breast cancer subtypes in a Spanish cohort. PLoS One. 2012;7(7):e40543. PMID: 22792365. PMCID PMC3394701.

53. Jeter JM, Han J, Martinez ME, Alberts DS, Qureshi AA, Feskanich D. Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study. Cancer Causes Control. 2012;23(9):1451-61. PMCID PMC3416973.

54. Nuño T, Gerald JK, Harris R, Martinez ME, Estrada A, García F. Comparison of breast and cervical cancer screening utilization among rural and urban Hispanic and American Indian women in the Southwestern United States. Cancer Causes Control. 2012 Aug;23(8):1333-41. PMID: 22710745.

55. Martínez ME, Jacobs ET, Baron JA, Marshall JR, Byers T. Dietary Supplements and Cancer Prevention: Balancing Potential Benefits Against Proven Harms. J Natl Cancer Inst 2012;104(10):732-9. PMID 22534785.

56. Haile RW, John EM, Levine AJ, Cortessis VK, Unger JB, Gonzales M, Ziv E, Thompson P, Spruijt-Metz D, Tucker KL, Bernstein JL, Rohan TE, Ho GY, Bondy ML, Martinez ME, Cook L, Stern MC, Correa MC, Wright J, Schwartz SJ, Baezconde-Garbanati L, Blinder V, Miranda P, Hayes R, Friedman-Jiménez G, Monroe KR, Haiman CA, Henderson BE, Thomas DC, Boffetta P. A review of cancer in U.S. Hispanic populations. Cancer Prev Res 2012;5(2):150-63. PMID: 22307564.

57. Jiang X, Castelao JE, Chavez-Uribe E, Fernandez Rodriguez B, Celeiro Muñoz C, Redondo CM, Peña Fernandez M, Novo Dominguez A, Pereira CD, Martínez ME, García-Caballero T, Fraga Rodriguez M, Antúnez J, Carracedo A, Forteza-Vila J, Gago-Dominguez M. Family history and breast cancer hormone receptor status in a Spanish cohort. PLoS One 2012;7(1):e29459. PMID: 22238615.

58. Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, Bandera EV, Gapstur S, Patel AV, Andrews K, Gansler T; American Cancer Society 2010 Nutrition and Physical Activity Guidelines Advisory Committee. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2012;62(1):30-67. PMID: 22237782.

59. Banegas MP, Gail MH, Lacroix A, Thompson B, Martinez ME, Wactawski-Wende J, John EM, Hubbell FA, Yasmeen S, Katki HA. Evaluating breast cancer risk projections for Hispanic women. Breast Cancer Res Treat. 2012;132(1):347-53. PMID: 22147080.

60. Hibler EA, Hu C, Jurutka PW, Martinez ME, Jacobs ET. Polymorphic Variation in the GC and CASR Genes and Associations with Vitamin D Metabolite Concentration and Metachronous Colorectal Neoplasia. Cancer Epidemiol Biomarkers Prev. 2012;21(2):368-75. PMID: 22144504. PMCID PMC3275650.

61. Garcia RZ, Carvajal SC, Wilkinson AV, Thompson PA, Nodora JN, Komenaka IK, Brewster A, Cruz GI, Wertheim BC, Bondy ML, Martínez ME. Factors that influence mammography use and breast cancer detection among Mexican-American and African-American women. Cancer Causes Control 2012;23(1):165-73. PMID: 22080276.

http://www.ncbi.nlm.nih.gov/pubmed/22827160




















Updated 07/2017

62. Bouton ME, Shirah GR, Nodora J, Pond E, Hsu CH, Klemens AE, Martinez ME, Komenaka IK. Implementation of educational video improves patient understanding of basic breast cancer concepts in an undereducated county hospital population. J Surg Oncol 2012;105(1):48-54. PMID: 21882193.

63. Greenberg ER, Anderson GL, Morgan DR, Torres J, Chey WD, Bravo LE, Dominguez RL, Ferreccio C, Herrero R, Lazcano-Ponce EC, Meza-Montenegro MM, Peña R, Peña EM, Salazar-Martínez E, Correa P, Martínez ME, Valdivieso M, Goodman GE, Crowley JJ, Baker LH. 14-day triple, 5-day concomitant and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Lancet 2011;378(9790):507-14. PMID 21777974. PMCID PMC3313469.

64. Nodora JN, Martz WD, Ashbeck EL, Jacobs ET, Thompson PA, Martínez ME. Primary care physician compliance with colorectal cancer screening guidelines. Cancer Causes Control 2011; 22(9):1277-87. PMID: 21710193.

65. Wang J, Joshi AD, Corral R, Siegmund KD, Le Marchand L, Martinez ME, Haile RW, Ahnen DJ, Sandler RS, Lance P, Stern MC. Carcinogen metabolism genes, red meat and poultry intake, and colorectal cancer risk. Int J Cancer 2011; 130(8):1898-1907. PMID: 21618522.

66. Win AK, Dowty JG, English DR, Campbell PT, Young JP, Winship I, Macrae FA, Lipton L, Parry S, Young GP, Buchanan DD, Martínez ME, Jacobs ET, Ahnen DJ, Haile RW, Casey G, Baron JA, Lindor NM, Thibodeau SN, Newcomb PA, Potter JD, Le Marchand L, Gallinger S, Hopper JL, Jenkins MA. Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes. Br J Cancer 2011; 105(1):162-169 PMID 21559014. PMCID: PMC3137400.

67. Komenaka IK, Hsu CH, Martinez ME, Bouton ME, Low BG, Salganick JA, Nodora J, Hibbard ML, Jha C. Preoperative Chemotherapy for Operable Breast Cancer Is Associated with Better Compliance with Adjuvant Therapy in Matched Stage II and IIIA Patients. Oncologist 2011; 16(6):742-51 PMID 21558134. PMCID: PMC3228209.

68. Leroy EC, Moore JH, Hu C, Martínez ME, Lance P, Duggan D, Thompson PA. Genes in the insulin and insulin-like growth factor pathway and odds of metachronous colorectal neoplasia. Hum Genet 2011; 129(5):503-12. PMID: 21221997.

69. Jacobs ET, Martínez ME, Jurutka PW. Vitamin D: marker or mechanism of action? Cancer Epidemiol Biomarkers Prev. 2011; 20(4):585-90. PMID: 21454423. PMCID PMC3074255.

70. Jacobs E, Martinez ME, Buckmeier J, Lance P, May M, Jurutka P. Circulating fibroblast growth factor-23 is associated with increased risk for metachronous colorectal adenoma. J Carcinog 2011;10:3. PMID: 21383962. PMCID PMC3049272.

71. Nuño T, Martinez ME, Harris R, Garcia F. A Promotora-administered group education intervention to promote breast and cervical cancer screening in a rural community along the U.S.-Mexico border: a randomized controlled trial. Cancer Causes Control 2011(22)3:367-74. PMID: 21184267.

72. Sanderson PR, Weinstein N, Teufel-Shone N, Martínez ME. Assessing colorectal cancer screening knowledge at tribal fairs. Prev Chronic Dis 2011;8(1)A16. PMID: 21159228. PMCID PMC3044027.

73. Brevik A, Joshi AD, Corral R, Onland-Moret NC, Siegmund KD, Le Marchand L, Baron JA, Martinez ME, Haile RW, Ahnen DJ, Sandler RS, Lance P, Stern MC. Polymorphisms in base excision repair genes as colorectal cancer risk factors and modifiers of the effect of diets high in red meat. Cancer Epidemiol Biomarkers Prev 2010;19(12):3167-3173. PMID: 21037106. PMCID PMC3058341.

74. Ooi SL, Martinez ME, Li CI. Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat 2010; 127(3):729-38. PMID: 21076864. PMCID PMC3081535.

75. Esparza-Romero J, Valencia ME, Martinez ME, Ravussin E, Schulz LO, Bennett PH. Differences in Insulin Resistance in Mexican and U.S. Pima Indians with Normal Glucose Tolerance. J Clin Endocrinol Metab 2010;95(11):E358-62. PMID: 20668044. PMCID PMC2968731.

76. Bouton ME, Nodora J, Hsu CH, Green A, Martinez ME, Komenaka IK. Understanding of breast cancer concepts in an undereducated county hospital population. J Surg Oncol 2010;102(5):398-403. PMID: 20734421.

77. Levine AJ, Figueiredo JC, Lee W, Conti DV, Kennedy K, Duggan DJ, Poynter JN, Campbell PT, Newcomb P, Martinez ME, Hopper JL, Le Marchand L, Baron JA, Limburg PJ, Ulrich CM, Haile RW. A






Updated 07/2017

candidate gene study of folate-associated one carbon metabolism genes and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2010;19(7):1812-21. PMID: 20615890. PMCID PMC2950115.

78. Martinez ME, Cruz GI, Brewster AM, Bondy ML, Thompson PA. What can we learn about disease etiology from case-case analyses? Lessons from breast cancer. Cancer Epidemiol Biomarkers Prev. 2010;19(11):2710-4. PMID: 20870734.

79. Komenaka IK, Martinez ME, Pennington RE, Hsu CH, Clare SE, Thompson PA, Murphy C, Zork NM, Goulet RJ Jr. Race and ethnicity and breast cancer outcomes in an underinsured population. J Natl Cancer Inst 2010;102(15):1178-87. PMID: 20574040.

80. Jacobs ET, Martínez ME, Campbell PT, Conti DV, Duggan D, Figueiredo JC, Haile RW, Leroy EC, Poynter JN, Thompson PA, Baron JA. Genetic variation in the retinoid X receptor and calcium-sensing receptor, and risk of colorectal cancer in the Colon Cancer Family Registry. Carcinogenesis 2010;31(8):1412-1416. PMID: 20558521. PMCID PMC2915636.

81. Thomson CA, Martinez ME. Coffee, tea, what beverage for me? Associations between beverage intake and colorectal neoplasia risk. J Natl Cancer Inst 2010;102(11): 749-51. PMID: 20453202.

82. Hibler EA, Jurutka PW, Egan JB, Hu C, Leroy EC, Martinez ME, Thompson PA, Jacobs ET. Association between polymorphic variation in VDR and RXRA and circulating levels of vitamin D metabolites. J Steroid Biochem Mol Biol 2010;121(1-2):438-41. PMID: 20307661. PMCID PMC2906637

83. Egan JB, Thompson PA, Ashbeck EL, Conti DV, Duggan D, Hibler E, Jurutka PW, Leroy EC, Martinez ME, Mount D, Jacobs ET. Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence. Cancer Res 2010; 70(4):1496-504. PMID: 20145122. PMCID PMC3019606.

84. Martinez ME, Gutierrez-Millan LE, Bondy M, et al. Comparative study of breast cancer in Mexican and Mexican-American Women. HEALTH 2010;2(9):1040-1048. Available at: http://www.scirp.org/Journal/PaperInformation.aspx?paperID=2632&JournalID=65.

85. Levine AJ, Figueiredo JC, Lee W, Poynter JN, Conti D, Duggan DJ, Campbell PT, Newcomb P, Martinez ME, Hopper JL, Le Marchand LL, Baron JA, Limburg PJ, Ulrich CM, Haile RW. Genetic variability in the MTHFR gene and colorectal cancer risk using the Colorectal Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2010; 19:89-100. PMID: 20056627. PMCID PMC2805460.

86. Campbell PT, Jacobs ET, Ulrich CM, Figueiredo JC, Poynter JN, McLaughlin JR, Haile RW, Newcomb PA, Potter JD, Le Marchand L, Green RC, Parfrey P, Younghusband HB, Cotterchio M, Gallinger S, Jenkins MA, Hopper JL, Baron JA, Thibodeau SN, Lindor NM, Limburg PJ, Martinez ME, for the Colon Cancer Family Registry. Case-control study of obesity, overweight and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst 2010;102(6): 391-400. PMID: 20208017. PMCID PMC2841037.

87. Figueiredo JC, Levine AJ, Lee WH, Conti DV, Poynter JN, Campbell PT, Duggan D, Lewinger JP, Martinez ME, Ulrich CM, Newcomb P, Potter J, Limburg PJ, Hopper J, Jenkins MA, Le Marchand L, Baron JA, Haile RW. Genes involved with folate uptake and distribution and their association with colorectal cancer risk. Cancer Causes Control 2010;21(4):597-608. PMID: 20037791. PMCID PMC2904058.

88. Wertheim BC, Martinez ME, Ashbeck EL, Roe DJ, Jacobs ET, Alberts DS, Thompson PA. Physical activity as a determinant of fecal bile acid levels. Cancer Epidemiol Biomarkers Prev 2009;18(5):1591-8. PMID: 19383885. PMCID PMC2743306.

89. Thompson PA, Wertheim BC, Roe DJ, Ashbeck EL, Jacobs ET, Lance P, Martinez ME, Alberts DS. Gender modifies the effect of urodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients. Cancer Prev Res 2009;2(12):1023-30. PMID: 19952360. PMCID PMC4120755

90. Benuzillo JG, Jacobs ET, Hoffman RM, Heigh RI, Lance P, Martinez ME. Rural- urban differences in colorectal cancer screening capacity in Arizona. J Community Health 2009;34(6):523-8. PMID: 19728054.

91. Ashbeck EL, Jacobs ET, Martinez ME, Gerner EW, Lance P, Thompson PA. Components of metabolic syndrome and metachronous colorectal neoplasia. Cancer Epidemiol Biomarkers Prev. 2009;18(4): 1134-43. PMID: 19318435. PMCID PMC2737414.


Updated 07/2017

92. Jacobs ET, Jrutka PW, Martinez ME, Alberts DS. Vitamin D, calcium, and colorectal neoplasia: new insights on mechanisms of action. Cancer Prev Res. 2009 Mar;2(3): 197-9. 2009 Mar 3. PMID: 19258545. PMCID PMC3078623.

93. Jacobs ET, Ahnen DJ, Ashbeck EL, Baron JA, Greenberg ER, Lance P, Lieberman DA, McKeown-Eyssen G, Schatzkin A, Thompson PA, Martinez ME. Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study. Am J Epidemiol 2009;169:654-666. PMID: 19147743. PMCID PMC2727215.

94. Martinez ME, Baron JA, Lieberman DA, Schatzkin A, Lanza E, Winawer SJ, Zauber AG, Jiang R, Ahnen DJ, Bond JH, Church TR, Robertson DA, Smith-Warner SA, Jacobs ET, Alberts DS, Greenberg ER. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 2009;136:832- 841. PMID: 19171141. PMCID PMC3685417.

95. Joshi AD, Corral R, Siegmund KD, Haile RW, Le Marchand L, Martinez ME, Ahnen DJ, Sandler, RS, Lance P, Stern MC. Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways, and colorectal cancer risk. Carcinogenesis. 2008; 30(3):472-9. PMID: 19029193. PMCID PMC2722151.

96. Martinez ME, Marshall JR, Giovannucci E. Diet and cancer prevention: the roles of observation and experimentation. Nat Rev Cancer 2008;8, 694-703. PMID 19143054.

97. Egan JB, Jacobs ET, Martinez ME, Gerner EW, Jurutka PW, Thompson, PA. Presence of a TA haplotype in the APC gene containing the common 1822 polymorphism and colorectal adenoma. Cancer Res 2008;68(14): 6006-13. PMID: 18632657.

98. Jacobs ET, Martinez ME, Alberts DS, Ashbeck EL, Gapstur, SM, Lance, P, Thompson, PA. Plasma insulin-like growth factor I is inversely associated with colorectal adenoma recurrence: a novel hypothesis. Cancer Epidemiol Biomarkers Prev 2008;17(2)300-05. PMID: 18250342.

99. Jacobs ET, Alberts DS, Foote JA, Green SB, Hollis BW, Yu Z, Martínez ME. Vitamin D deficiency in southern Arizona. Am J Clin Nutr 2008;87: 608-13. PMID: 18326598. PMCID PMC4113473.

100. Martinez ME, Nielson CM, Nagle R, Lopez AM, Kim C, Thompson P. Breast cancer among Hispanic and non-Hispanic women in Arizona. J Health Care Poor Underserved 2007;18:130-45. PMID: 18065856.

101. Martinez ME, Jacobs ET, Ashbeck EL, Sinha R, Lance P, Alberts DS, Thompson PA. Meat intake, preparation methods, mutagens, and colorectal adenoma recurrence. Carcinogenesis 2007;28:2019-27. PMID: 17690112.

102. Jacobs ET, Thompson PA, Martinez ME. Diet, gender, and colorectal neoplasia. J Clin Gastroenterol 2007;41:731-746. PMID: 17700421.

103. Jacobs ET, Martinez ME, Alberts DS, Jiang R, Lance P, Lowe KA, Thompson PA. Association between body size and colorectal adenomas. Clin Gastroenterol Hepatol 2007;5:982-904. PMID: 17553754. PMCID PMC 2729188.

104. Jacobs ET, Alberts DS, Benuzillo J, Hollis BW, Thompson PA, Martínez ME. Serum 25(OH)D levels, dietary intake of vitamin, and colorectal adenoma recurrence. J Steroid Biochem Mol Biol 2007;103:752-6. PMID: 17223551. PMCID PMC2563804.

105. Martínez ME, Jacobs ET. Calcium supplementation and prevention of colorectal neoplasia: lessons from clinical trials. J Natl Cancer Inst 2007;99:99-100. PMID: 17227988.

106. Kushi LH, Byers, T, Doyle C, Bandera EV, McCullough M, McTiernan A, Gansler T, Andrews KS, Thun MJ; American Cancer Society 2006 Nutrition and Physical Activity Guidelines Advisory Committee. CA Cancer J Clin 2006;56(5):254-81. PMID: 17005596.

107. Martínez ME, Giovannucci E, Jiang R, Henning SM, Smith-Warner S, Jacobs ET, Thompson PA, Alberts DS. Folate fortification of the US food supply, plasma folate, homocysteine, and colorectal adenoma recurrence. Int J Cancer 2006;119 (6):1440-1446. PMID: 16615116.

108. Jacobs ET, Lanza E, Alberts DS, Hsu C-H, Jiang R, Schatzkin A, Thompson PA, Martínez ME. Fiber, sex, and colorectal adenoma: Results of a pooled analysis. Am J Clin Nutr 2006;83:343 – 349. PMID: 16469993.

http://www.ncbi.nlm.nih.gov/pubmed?term=%22McCullough%20M%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22McTiernan%20A%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Gansler%20T%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Andrews%20KS%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Thun%20MJ%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Thun%20MJ%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22American%20Cancer%20Society%202006%20Nutrition%20and%20Physical%20Activity%20Guidelines%20Advisory%20Committee%22%5BCorporate%20Author%5D


Updated 07/2017

109. Einspahr JG, Martínez ME, Jiang R, Hsu C, Bhattacharrya AK, Ahnen DJ, Jacobs ET, Houlihan PS, Webb CR, Alberts DS, Hamilton SR. Association of Ki-ras proto-oncogene mutation and p53 gene product overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics. Cancer Epidemiol Biomarkers Prev 2006;15:1443-1450. PMID: 16896030. PMCID PMC3547362.

110. Martínez ME, Thompson PA, Jacobs ET, Giovannucci E, Jiang R, Klimecki W, Alberts DS. Dietary factors and biomarkers involved in the methylenetetrahydrofolate reductase genotype-colorectal adenoma pathway. Gastroenterology 2006;131:1706-1716. PMID: 17087956.

111. Alberts, DS, Martínez, ME, Hess LM, Einspahr JG, Green SB, Bhattacharyya AK, Guillen J, Krutzch M, Batta AK, Salen G, Fales L, Koonce K, Parish D, Clouser M, Roe D, Lance P, and the Phoenix and Tucson Gastroenterologist Networks. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst 2005;97:846-853. PMID: 15928305.

112. Martínez, ME. Primary Prevention of Colorectal Cancer: Lifestyle, nutrition, exercise. Recent Results Cancer Res 2005;166:177-211. PMID: 15648191.

113. Jacobs ET, Haussler MR, Martínez ME. Vitamin D activity and colorectal neoplasia: A pathway approach to epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2005;14(9):2061-2063. PMID: 16172209.

114. Rebbeck TR, Martínez ME, Sellers TA, Shields PG, Wild CP, Potter JD. Genetic variation and cancer: improving the environment for publication of association studies. Cancer Epidemiol Biomarkers Prev 2004;13:1985-1986. PMID: 15598750.

115. Jacobs ET, Jiang R, Alberts DS, Greenberg ER, Gunter EW, Karagas MR, Lanza E, Ratnasinghe L, Reid ME, Schatzkin A, Smigh-Warner S, Wallace K, Martínez ME. Selenium and colorectal adenoma: results of a pooled analysis. J Natl Cancer Inst 2004;96:1669-1675. PMID: 15547179.

116. Jacobs ET, Giuliano AR, Martínez ME, Hollis BW, Reid ME, Marshall JR. Plasma levels of 25-Hydroxyvitamin D, 1,25-Dihydroxyvitamin D and the risk of prostate cancer. J Steroid Biochem Mol Biol 2004;89-90:533-537. PMID: 15225833.

117. Chen Z, Alberts DS, Marshall J, Stini W, Martínez ME, Guillen J, Roe D. Wheat bran fiber supplementation and bone loss among older people. Nutrition 20:747-751, 2004. PMID: 15325680.

118. Martínez ME, Henning SM, Alberts, DS. Folate and colorectal neoplasia: relation between plasma and dietary markers of folate and adenoma recurrence. Am J Clin Nutr 2004;79:691-697. PMID: 15051616

119. Jacobs ET, Giuliano AR, Roe DJ, Guillen-Rodriguez JM, Hartz VL, Whitacre RC, Alberts DS, Martínez ME. Dietary change in intervention trial of wheat bran fiber and colorectal adenoma recurrence. Ann Epidemiol 2004;14:280-286. PMID: 15066608.

120. Martínez ME, Reid ME, Jiang R, Einspahr J, Alberts DS. Accuracy of self-reported smoking status and assessment of quit rate among participants in a chemoprevention trial. Prev Med 2004;38:492-497. PMID: 15020184.

121. Reid ME, Marshall JR, Roe D, Lebowitz M, Alberts DS, Martínez ME. Smoking exposure as a risk factor for prevalent and recurrent colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2003;12:1006-1011. PMID: 14578135.

122. Martínez ME, O’Brien TG, Fultz KE, Babbar N, Yerushalmi H, Qu N, Guo Y, Boorman D, Einspahr J, Alberts DS, Gerner EW. Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the Ornithine Decarboxylase gene. Poc Natl Acad Sci 2003;100:7859-7864. PMID: 12810952. PMCID PMC164678.

123. Einspahr JG, Krouse RS, Yochim JM, Danenberg PV, Danenberg KD, Bhattacharyya AK, Martínez ME, Alberts DS. Association between cyclooxygenase expression and colorectal adenoma characteristics. Cancer Res 2003;63:3891-389. PMID: 12873979

124. Thompson CA, LeWinn, K, Newton TR, Alberts DS, Martínez ME. Nutrition and diet in the development of gastrointestinal cancer. Curr Oncol Rep 2003;5:192-202. PMID: 12667416.

125. Alberts DS, Einspahr J, Earnest DL, Krutzsch M, Lin P, Hess LM, Heddens DK, Roe DJ, Martínez ME, Salen G, Batta AK. Fecal bile acid concentrations in a subpopulation of the Wheat Bran Fiber colon polyp trial. Cancer Epidemiol Biomarkers Prev 2003;12:1-4. PMID: 12646507.


Updated 07/2017

126. Jacobs ET, Giuliano AR, Roe DJ, Guillen-Rodriguez JM, Alberts DS, Martínez ME. Baseline dietary fiber intake and colorectal adenoma recurrence among participants in the Wheat Bran Fiber Trial. J Natl Cancer Inst 2002;94: 1620-1625. PMID: 12419788.

127. Jacobs ET, Giuliano AR, Roe DJ, Guillen-Rodriguez JM, Hess LM, Alberts DS, Martínez ME. Intake of supplemental and total fiber and risk of colorectal adenoma recurrence in the Wheat Bran Fiber trial. Cancer Epidemiol Biomarkers Prev 2002;11:906-914. PMID: 12223437.

128. Martínez ME, Marshall JR, Sampliner R, Wilkinson J, Alberts DS. Calcium, vitamin D, and risk of adenoma recurrence (United States). Cancer Causes Control 2002;13:213-220. PMID: 12020102.

129. Martínez ME. Hormone replacement therapy and adenoma recurrence: Implications for its role in colorectal cancer risk (invited editorial). J Natl Cancer Inst 2001;93:1764-1765. PMID: 11734585

130. Maltzman T, Knoll K, Martínez ME, Byers T, Stevens BR, Marshall JR, Reid ME, Einspahr J, Hart N, Bhattacharyya AK, Kramer CB, Sampliner R, Alberts DS, Ahnen DJ. Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: Relationship to histologic and clinical characteristics. Gastroenterology 2001;121:302-309. PMID: 11487539.

131. Martínez ME, Sampliner R, Marshall JR, Bhattacharyya AK, Reid ME, Alberts DS. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology 2001;120:1077-1083. PMID: 11266371.

132. Alberts DS, Martínez ME, Roe DJ, Guillen-Rodriguez JM, Marshall JR, van Leeuwen JB, Reid ME, Ritenbaugh C, Vargas PA, Bhattacharyya AB, Earnest DL, Sampliner RE. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. N Engl J Med 2000;342:1156-1162. PMID: 10770980.

133. Martínez ME, Marshall JR, Graver E, Whitacre RC, Woolf K, Ritenbaugh C, Alberts DS. Reliability and validity of a self-administered food frequency questionnaire in a chemoprevention trial of adenoma recurrence. Cancer Epidemiol Biomarkers Prev 1999;8:941-946. PMID: 10548325.

134. Martínez ME, Maltzman T, Marshall JR, Einspahr J, Reid ME, Sampliner R, Ahnen DJ, Hamilton SR, Alberts DS. Risk factors for ki-ras protooncogene mutation in sporadic colorectal adenomas. Cancer Res 1999;59:5181-5185. PMID: 10537295.

135. Martinez ME, Marshall JR, Graver E, Whitacre RC, Woolf K, Ritenbaugh C, Alberts DS. Reliability and validity of a self-administered food frequency questionnaire in a chemoprevention trial of adenoma recurrence. Cancer Epidemiol Biomarkers Prev. 1999 Oct 8;8(10):941-6. PMID: 10548325.

136. Martínez ME, Heddens D, Earnest DL, Bogert CL, Roe D, Einspahr J, Marshall JR, Alberts DS. Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosa. J Natl Cancer Inst 1999;91:950-953. PMID: 10359547.

137. Earnest DL, Sampliner RE, Roe DJ, van Leeuwen B, Guillen J, Reid M, Martínez ME, Marshall JR, Alberts DS. Progress report: The Arizona phase III study of the effect of wheat bran fiber on recurrence of adenomatous colon polyps. Am J Med 1999;106:43S-45S. PMID: 10089115.

138. Martínez ME, Reid ME, Guillen-Rodriguez J, Marshall JR, Sampliner R, Aickin M, Ritenbaugh C, van Leeuwen B, Mason-Liddil N, Giuliano A, Vargas PA, Alberts DS. Design and baseline characteristics of study participants in the wheat bran fiber trial. Cancer Epidemiol Biomarkers Prev 1998;7:813-816. PMID: 9752991.

139. Martínez ME, Marshall JR, Sechrest L. Invited commentary: Factor analysis and the search for objectivity. Am J Epidemiol 1998;148 (1):17-19. PMID: 9663398

140. Grodstein F, Martínez ME, Platz, EA, Giovannucci E, Colditz GA, Kauzsky M, Fuchs C Stampfer MJ. Postmenopausal hormone use and the risk of colorectal cancer and adenoma. Ann Int Med 1998;128:705-712. PMID: 9556463.

141. Martínez ME, Willett WC. Calcium, vitamin D, and colorectal cancer: A review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 1998;7:163-168. PMID: 9488592

142. Martínez ME, Giovannucci E. Diet and the prevention of cancer. Cancer Metastasis Rev. 1997;16:357-376. PMID: 9433645.


Updated 07/2017

143. Platz EA, Martínez ME, Grodstein F, Fuchs, CS, Colditz, GA, Stampfer MJ, Giovannucci E. Parity and other reproductive factors and risk of adenomatous polyps of the distal colorectum (United States). Cancer Causes Control 1997;8:894-903. PMID: 9427432.

144. Martínez ME, McPherson RS, Levin B, Glober, GA. A case-control study of dietary intake and other lifestyle risk factors for hyperplastic polyps. Gastroenterology 1997;113:423-429. PMID: 9247459

145. Martínez ME, Giovannucci E, Spiegelman D, Willett WC, Colditz GA. Leisure-time physical activity, body size, and colon cancer in women. J Natl Cancer Inst 1997;89:948-955. PMID: 9214674.

146. Martínez ME, Grodstein F, Giovannucci E, Colditz GA, Speizer FE, Hennekens C, Rosner B, Willett WC, Stampfer MJ. A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 1997;6:1-5. PMID: 8993789.

147. Lipworth L, Martínez ME, Angell J, Hsieh CC, Trichopoulos D. Olive oil and human cancer: an assessment of the evidence. Prev Med 1997;26:181-190. PMID: 9085386.

148. Giovannucci E, Martínez ME. Tobacco, colorectal cancer and adenomas: a review of the evidence. J Natl Cancer Inst 1996;88:1717-1730. PMID: 8944002.

149. Martínez ME, Giovannucci EL, Colditz GA, Stampfer MJ, Hunter DJ, Speizer FE, Wing A, Willett WC. Calcium, vitamin D, and the occurrence of colorectal cancer among women. J Natl Cancer Inst 1996;88:1375-1382. PMID: 8827015.

150. Martínez ME, McPherson RS, Annegers JF, Levin B. Association of diet and colorectal adenomatous polyps: a case-control study among endoscoped individuals. Epidemiology 1996;7:264-268. PMID: 8728439.

151. Martínez ME, McPherson RS, Levin B, and Annegers JF. Aspirin use and other nonsteroidal anti-inflammatory drugs as risk factors for colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev 1995;4:703-707. PMID: 8672985.

152. Martínez ME, McPherson RS, Levin B, and Annegers JF. Cigarette smoking and alcohol consumption as risk factors for colorectal adenomatous polyps. J Natl Cancer Inst 1995;87:274-279. PMID: 7707418

153. García ME, van Eys J, Wang YM. Iron nutrition in childhood malignancy. JPEN 1989;13:162-167. PMID: 2709601.

154. Collins CL, García ME. Position of The American Dietetic Association: nutrition intervention in the treatment of human immunodeficiency virus infection (invited). J Am Diet Assoc 1989;89:839-841. PMID: 2723313.

155. García ME, Collins CL, Mansell PW. The acquired immune deficiency syndrome: Nutritional Complications and Assessment of Body Weight Status. Nutr Clin Pract 1987;2:108-111.

Invited Book Chapters 1. Jacobs ET, Thompson PA, Martínez ME. Environmental and Lifestyle Issues in Colorectal Cancer. In:

Principles and Practice of Gastrointestinal Oncology. Kelsen, Daly, Kern, Levin, Tepper, Van Cutsem (eds.). 2nd edition. Lippincott Williams & Wilkins, pp. 511-526, 2007.

2. Martínez ME, Jacobs ET, Alberts DS. Dietary Fiber and Carbohydrates. In: Nutritional Oncology. Heber D, Blackburn GL, Go VL (eds.). 2nd edition. Elsevier: San Diego, CA, pp. 521-530, 2006.

3. Martínez, ME. Mechanisms Associating Physical Activity with Cancer Incidence: Exercise and Prostaglandins. In: Cancer Prevention and Management through Exercise and Weight Control. A. McTiernan (ed). Taylor and Francis: Boca Raton, FL, pp. 177-181, 2006.

4. Martínez ME Jacobs, ET. Diet and environment, role in colon cancer. In: Encyclopedia of Gastroenterology L. R. Johnson, (ed.). Elsevier: San Diego, CA, Vol. 1, pp. 593-597, 2004.

5. Martínez ME, Marshall JR. Colorectal cancer: Environmental and lifestyle issues (invited). In: Gastrointestinal Oncology: Principles and Practice, Kelsen DP, Daly JM, Kern SE, Levin B, Tepper JE (eds.). Lippincott Williams and Wilkins: Philadelphia, PA, pp. 665-683, 2002.

6. Martínez ME, Giovannucci E, Alberts DS. Prevention of colorectal cancer: Epidemiological evidence and chemoprevention. In: Atlas of Clinical Oncology: Cancer of the Lower Gastrointestinal Tract, Willet CG (ed.). BC Decker Inc: Hamilton, Ontario, pp. 7-32, 2001.


Updated 07/2017

7. Martínez ME, Marshall JR, Alberts DS. Dietary fiber, carbohydrates, and cancer. In: Nutritional Oncology, Heber D, Blackburn GL, Go VL (eds.). Academic Press: San Diego, CA, pp. 185-194, 1999.

Reports/Other Publications

1. Martínez ME, Greenberg ER. More aspirin for less cancer? J Natl Cancer Inst 18;99:582-3. (Invited

Editorial) 2. Martínez ME, Thomson CA, Smith-Warner S. Soy and Breast Cancer: The Controversy Continues. J

Natl Cancer Inst 2006;98:430-431. (Invited Editorial). 3. Martínez ME. Genetic Epidemiology: the Value of Population Differences. Cancer Epidemiol

Biomarkers Prev 2006;15:6. (Invited Editorial). 4. Alberts DS, Potter JD, Martínez ME, Hess LM, Stopeck A, Lance P. What happened to the Coxibs on

the Way to the cardiologist? Cancer Epidemiol Biomarkers Prev 2005;14:555-556. PMID 15767326 5. Thompson CA, LeWinn K, Newton TR, Alberts DS, Martínez ME. Nutrition and diet in the development

of gastrointestinal cancer. Current Oncology Reports 2003;5:192-202. PMID 12667416 6. Byers T, Nestle M, McTiernan A, Doyle C, Currie-Williams C, Gansler T, Thun M, and the American

Cancer Society 2001 Nutrition and Physical Activity Guidelines Committee. American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer with Healthy Food Choices and Physical Activity. CA Cancer J Clin 2002;52:92-119. PMID 11929008

7. Martínez ME. Hormone replacement therapy and adenoma recurrence: Implications for its role in colorectal cancer risk (invited editorial). J Natl Cancer Inst 2001;93:1764-1765.

8. Martínez ME. Observational epidemiological studies versus clinical trials of nutrition and cancer: Weighing the evidence. In: American Society of Clinical Oncology Educational Book (37th Annual Meeting, Spring 2001), Perry MC (ed.). American Society of Clinical Oncology: Alexandria, VA, pp. 9-14, 2001.

9. Conquering Colorectal Cancer: a Blueprint for the Future. National Cancer Institute. April, 2000. http://planning.cancer.gov/cprgreport/

GRANTS AND CONTRACTS Current Research Projects Grant Name: 1/2 SDSU/UCSD Cancer Center Comprehensive Partnership Funding Agency: NIH/NCI (2U54CA132379-06A1) Role: Lead Principal Investigator (S. Crowe, E. Arredondo, M. Sussman, MPIs) Percent effort: 25% Annual Direct Costs: $942,896 Period of Funding: 2007-2020 Description: The specific objectives of the SDSU/UCSD Comprehensive Cancer Center

Partnership is to continue to develop outstanding programs in research, research education, and community outreach to understand causes for cancer health disparities and to reduce the burden of cancer among Hispanic/Latino communities in our catchment areas of San Diego and Imperial counties.

Grant Name: UCSD Moores Cancer Center Support Grant (S. Lippman, PI) Funding Agency: NIH/NCI (5 P30 CA23100-28) Role: Program Co-leader, Reducing Cancer Disparities Program Percent effort: 5% Annual Direct Costs: $2,703,607


Updated 07/2017

Period of Funding: 2014-2019 Description: Dr. Martinez is Co-Leader of the Reducing Cancer Disparities Program at the UCSD

Moores Cancer Center. The goal of this support grant is to reduce the morbidity and mortality from cancer in San Diego County.

Grant Name: The Reproductive Window in Young Adult Cancer Survivors Funding Agency: NIH/NCI 1R01HD080952-01 Role: Co-Investigator (Su, PI) Percent effort: 5% Period of Funding: 2014-2019 Description: Using innovative approaches to recruitment and large-scale biosample collection,

the study will identify determinants of the window of ovarian function after cancer in order to guide patient counseling, individualize risks and preserve opportunities for biologic parenthood.

Grant Name: Strengthen NCI-supported Community Outreach through CHE of the NON Funding Agency: NIH/NCI 3P30CA023100-29S5 Role: Project Director (Lippman, PI) Percent effort: 2% Annual Direct Costs: $241,936 Period of Funding: 2015-2018 Description: Through this administrative supplement, we propose to support a community health

educator (CHE) under the NCI’s National Outreach Network (NON) and linked to the regional Geographic Management of Cancer Health Disparities Program (GMaP) to conduct inreach and outreach activities related to clinical trial accrual, screening and early detection of cancer.

Grant Name: GPS exposure to environments & relations with biomarkers of cancer risk Funding Agency: NIH/NCI 1R01CA179977-01 Role: Co- Investigator (Kerr, PI) Percent effort: 5% Period of Funding: 2013-2017 Description: The purpose of this study is to advance methods of cancer risk exposure

assessment by measuring both neighborhood access and total environment exposure to healthy environments by dynamically integrating Global Positioning System (GPS) data with Geographical Information System (GIS) data.

Grant Name: Optimizing colorectal cancer and polyp surveillance after colorectal polypectomy Funding Agency: Veterans Affairs Health Services R&D 1 I01 HX001574-01A1 Role: Co-Investigator (Gupta, PI) Percent effort: 4% Period of Funding: 2015-2019 Description: This 4-year project will create a VA Colonoscopy Cohort of all Veterans who have

undergone colonoscopy with polypectomy since 1999, develop and validate natural language processing algorithms to abstract discrete data of interest from free text colonoscopy and pathology reports, and use these data to develop and validate a novel model for predicting risk for metachronous advanced adenoma.

Completed Research Projects Grant Name: Epigenetic Features of Pregnancy-Associated Breast Cancer in Hispanic Women Funding Agency: NIH/NCI 1U01CA153086-01 Role: Co- Principal Investigator (B. Futscher, co-PI)


Updated 07/2017

Percent effort: 21% Annual Direct Costs: $250,000 Period of Funding: 2010-2015 Description: The objective of this research project is to compare the epidemiological and

epigenetic profiles of breast cancer tumors diagnosed in the transient postpartum period of increased risk against those that are diagnosed outside this period.

Grant Name: Informed Consent for Biospecimen Collection and Data Sharing among Low-

income, Uninsured and Underinsured Women: Is it a Matter of Trust? Funding Agency: NIH U54 HL108460 Role: Co- Investigator (Komenaka, DBP6 PI, Ohno-Machado, U54 PI) Percent effort: 4.1% Period of Funding: 2013-2015 Description: We propose to conduct a pilot study to compare two methods of informed consent

delivery for biospecimen collection in a population of individuals receiving care at a safety net health care setting in the Phoenix, Arizona metropolitan area. We specifically aim to: (1) Compare the rate of informed consent for biospecimen collection and data sharing for research solicited by a physician with the rate of informed consent solicited through a research assistant; (2) Explore differences in informed consent delivery by the following factors: age, race/ethnicity, health literacy, cancer risk perception, language use, and breast cancer vs. non-cancer diagnosis.

Grant Name: Surveillance, Epidemiology, and End Results (SEER) Program Funding Agency: NCI/PHI (30900-03-01) Role: Principal Investigator Percent effort: 15% Annual Direct Costs: $83,951 Period of Funding: 2014-2015 Description: To assess and complete evaluations for cancer outcomes from citizens and

organizations within San Diego, Imperial, and Orange Counties. Grant Name: Specialized Cancer Center Support Grant Administrative Supplement to Dr. Martinez Funding Agency: NIH/NCI (5 P30 CA23100-21) Role: Principal Investigator Percent effort: 0% Period of Funding: 2013-2014 Description: This supplemental award provides supplemental support for the project entitled

"Characterization of tumor microenvironment remodeling and molecular changes associated with parity and breastfeeding in Hispanic breast cancer patients".

Grant Name: Transdisciplinary Research on Energetics and Cancer (TREC) Developmental Project Funding Agency: NIH/NCI Role: Principal Investigator (UCSD Site) Percent effort: 2% Period of Funding: 2013-2014 Description: The objective of this pilot project is to assess the contribution of obesity to

inflammation in the tumor microenvironment that may explain the racial disparity in ER+ breast cancer in postmenopausal women.

Grant Name: Post-Baccalaureate Training Program to Address Breast Cancer Disparities in

Mexican/Mexican-American Women Funding Agency: Komen KG090934 Role: co-Principal Investigator (with P. Thompson)


Updated 07/2017

Percent effort: 5% Annual Direct Costs: $203,582 Period of Funding: 2007-2012 (NCE) Description: The primary training objective of this program is to provide a structured training

program to empower trainees with the necessary skills to address breast cancer health disparities in Hispanics and provides an outstanding opportunity to assess whether changing social and cultural factors influence clinical, histological, and molecular patterns of breast cancer in women of Mexican descent.

Grant Name: Cancer Prevention and Control Training Program Funding Agency: NIH/NCI R25T CA78447 Role: Co-Director (D. Alberts, PI) Percent effort: 20% Annual Direct Costs: $500,000 Period of Funding: 2005-2011 Description: This is a training grant in Cancer Prevention and Control that provided training for

post-doctoral fellows pursuing careers in the various disciplines of cancer prevention and control.

Grant Name: Arizona Cancer Center Support Grant (D. Alberts, PI) Funding Agency: NIH/NCI (P30 CA023074-31) Role: Program Leader and Administrative Core (Cancer Health Disparities) Percent effort: 8% Annual Direct Costs: $19,466 Period of Funding: 2004-2011 Description: The major goal of this project is to provide organizational infrastructure for the

promotion of interdisciplinary research and the collective use of resources. Funds for Dr. Martinez support her role as Program Leader and Administration in Cancer Disparities.

Grant Name: Comparative Study of Breast Cancers and their Risk Factors

among Mexican Women in Mexico and the U.S. Funding Agency: Avon Foundation Role: Principal Investigator Percent effort: 10% Annual Direct Costs: $253,800 Period of Funding: 2006-2011 Description: The Arizona Cancer Center in collaboration with other institutions has been awarded

an NCI-Avon grant which will assess whether changing social and cultural factors influence clinical, histological, and molecular patterns of breast cancer in women of Mexican descent.

Grant Name: Development of a Program to Increase Colorectal Cancer Screening in Arizona Funding Agency: American Cancer Society Role: Principal Investigator Percent effort: 10% Annual Direct Costs: $600,000 Period of Funding: 2005-2010 (NCE through 2011) Description: This funding was part of the Richard H. Hollen Professorship endowment that was

awarded to Dr. Martinez to facilitate research and stakeholder involvement to increase rates of colorectal cancer screening in Arizona.


Updated 07/2017

Grant Name: Specialized Program of Research Excellence in Gastrointestinal Cancer (E Gerner, PI)

Funding Agency: NCI/NIH P50 CA95060 Role: Co-Investigator of Project I: Genetic Variability as Prognostic or Predictive Factors

in Colorectal Intraepithelial Neoplasia Percent effort: 5% Annual Direct Costs: $10,544 Period of Funding: 2002-2010 Description: This Specialized Program of Research Excellence (SPORE) is a grant emphasizing

translational research in gastrointestinal cancer. Dr. Gerner is PI of this SPORE, which is focusing on cancers of the colon, esophagus and pancreas. Projects address topics in GI cancer screening, prevention and treatment.

Grant Name: Colorectal Neoplasia in SELECT Participants (P. Lance, PI) Funding Agency: NCI/NIH R01CA124862-01A1 Role: Co- Investigator Percent effort: 5% Annual Direct Costs: $10,184 Period of Funding: 2007-2011 Description: The main goal of this project is to assess if the treatment with nutritional

supplements of selenium and/or vitamin E will reduce the prevalence of colorectal adenomas and the incidence of colorectal adenomas in SELECT participants.

Grant Name: Colon Cancer Prevention Program Project (P Lance, PI) Funding Agency: NCI/NIH (P01 CA41108) Role: Project Leader: Project III-Lifestyle and genetic determinants of IGF-1 as risk

factors for advanced colorectal neoplasia Co-Leader: Project II-Advanced adenomas and serrated adenomas as precursors to colorectal cancer Co-Core Leader: Biometry and Data Management Core

Percent effort: 24% Annual Direct Costs: $508,686 Period of Funding: 2005-2010 (NCE through 2011) Description: The goals of this program are to develop new strategies to prevent colon cancer and

to reduce the high morbidity and mortality rates caused by this malignancy. Grant Name: Development of a Program to Increase Colorectal Cancer Screening in Arizona.

Application for the Richard R. Hollen Professorship Special Research Grant on Cancer Prevention

Funding Agency: American Cancer Society Role: Principal Investigator Percent effort: 10% Annual Direct Costs: $100,000 Period of Funding: 2006-2010 (NCE through 2011) Description: In close partnership with the Great West Division of the American Cancer Society

(ACS), we propose to develop a program focused on increasing CRC screening rates in the state of Arizona, with an overall goal of increasing to 75% by the year 2010 the proportion of the Arizona population aged 50 years and older who undergoes CRC screening.

Grant Name: Dietary Hetrocyclic Amines, Genetic Susceptibility, and Risk of Colorectal Cancer Funding Agency: NCI/NIH KO1 CA79069 Role: Principal Investigator


Updated 07/2017

Percent effort: 100% Annual Direct Costs: $82,872 Period of Funding: 1998-2003 Description: The goal of this project is to investigate the role of heterocyclic amines in food and

genetic polymorphisms as they relate to Ki-ras mutations and adenoma recurrence. Grant Name: Folate Status and Colorectal Neoplasia Funding Agency: Cancer Research Foundation of America Role: Principal Investigator Annual Direct Costs: $35,000 Period of Funding: 1999-2000 Description: The goal of this proposal is to investigate the effects of key indices of folate status

as they relate to adenoma recurrence. Grant Name: Four Corners Breast Cancer Study Funding Agency: NCI/NIH RO1 CA78802 Role: Principal Investigator Percent effort: 5% Annual Direct Costs: $144,260 Period of Funding: 1999-2004 Description: The hypotheses tested include: 1) timing and weight gain and loss are associated

with breast cancer risk; and 2) variants in genes associated with the insulin pathway modify the metabolic response to weight change and body size are associated with breast cancer risk.

Grant Name: Dietary isothiocyanates, glutathionse S-transferases, and colorectal neoplasia Funding Agency: American Institute for Cancer Research Role: Principal Investigator Annual Direct Costs: $77,564 Period of Funding: 2000-2002 Description: The goal of this study is to determine if dietary isothiocyanates, in combination with

GST genotype and phenotype, are associated with recurrence of colorectal adenomatous polyps.

Grant Name: Colon Cancer Prevention Program Project (DS Alberts, PI) Funding Agency: NCI/NIH PO1 CA41108 Role: co-Principal Investigator

Project Leader: Environmental and Genetic Epidemiology of Colorectal Adenomas Core Leader: Nutrition Core Core Leader: Adherence Core

Percent effort: 25% total Annual Direct Costs: $3,541,037 Period of Funding: 2000-2005 Description: The goals of this program are to develop new strategies to prevent colon cancer and

to reduce the high morbidity and mortality rates caused by this malignancy. Grant Name: A Comprehensive Plan to Ensure Capacity for Screening and Early Detection of

Colorectal Cancer in Arizona (P Lance, PI) Funding Agency: ADHS (ACS Subcontract) HP 454367 Role: Co-Investigator Percent effort: 10% Annual Direct Costs: $127,683 Period of Funding: 2004-2005


Updated 07/2017

Description: In this joint application from the Arizona Cancer Center and the American Cancer Society, we propose to develop a program focused on increasing CRC screening in Arizona.

Grant Name: Arizona Family Registry for Colorectal Cancer Studies (MP Lance, PI) Funding Agency: NCI/NIH RO1 2 U01 CA74799-05 Role: Co-Investigator Percent effort: 1% Annual Direct Costs: $123,934 Period of Funding: 2003-2007 Description: The goal of this project is to establish a population based familial colon cancer

registry using the Cancer Registry databases of Colorado and Arizona as the ascertainment source for index cases.

Grant Name: Fiber and Colorectal Adenomas: A Pooling Project (E Jacobs, PI) Funding Agency: NIH/NCI R03 CA110814 Role: Co-Investigator Percent effort: 3% Annual Direct Costs: $50,000 Period of Funding: 2004-2007 Description: A pooling project to investigate fiber and colorectal adenoma recurrence. Grant Name: Advanced colorectal neoplasia following polypectomy Funding Agency: NIH/NCI Role: Principal Investigator Percent effort: 20% Annual Direct Costs: $258,552 Period of Funding: 2004 – 2007 Description: The goal of this research is to identify factors that place individuals at high or low

risk for development of advanced neoplasms after colonoscopic polypectomy by pooling individual data from eight completed adenoma studies.

Grant Name: Cancer Information Services – Arizona Cancer Center Subcontract Funding Agency: NCI Role: Principal Investigator Percent effort: 1% Annual Direct Costs: $125,086 Period of Funding: 2007-2008 Description: The CIS Partnership Program brings cancer information to organizations that reach

people who traditionally do not seek health information. Partnership activities include a nationally coordinated, regionally focused program committed to reaching minority and underserved populations that do not have adequate access to health information and services.

Grant Name: Arizona Cancer Center Support Grant Administrative Supplement (D. Alberts, PI) Funding Agency: NCI/NIH P30 CA23074-29S3 Role: Co-Director Percent effort: 10% Annual Direct Costs: $199,089 Period of Funding: 2007-2008 Description: This is a supplement to the Cancer Center Support Grant. The funding from this

administrative supplement is for the development of a Center for Cancer Health Disparities.


Updated 07/2017

Grant Name: Arizona Cancer Center Support Grant Supplement (D. Alberts, PI) Funding Agency: NIH/NCI Role: Co-Investigator Percent effort: 10% Annual Direct Costs: $309,669 Period of Funding: 2006-2008 Description: This is a supplement to the cancer center support grant. The project is a Comparative

Study of Breast Cancers and their Risk Factors among Mexican Women in Mexico and the U.S.

Grant Name: Modeling Dietary Contributions to Arsenic Dose Funding Agency: U.S. Environmental Protection Agency Role: co-Principal Investigator Percent effort: 5% Annual Direct Costs: $249,999 Period of Funding: 2008 – 2010 Description: The investigators will generate and validate arsenic exposure indicators based on

diet over a range of drinking water arsenic concentrations and a health outcome indicator modeling the effect of diet on arsenic methylation.

Pending Research Projects Grant Name: Infrastructure for Establishing a Hispanic/Latina Breast Cancer Survivorship Cohort Funding Agency: National Cancer Institute Role: Lead Principal Investigator Percent effort: 30% Annual Direct Costs: $1,671,364 Period of Funding: 2017-2022 Description: Invasive breast cancer is the most commonly diagnosed malignancy and the leading

cause of cancer death among Hispanic/Latina women in the United States but Hispanic ethnicity is largely under-represented in etiological and survivorship cohorts (< 4%). This precludes meaningful evaluation of population-specific outcomes that would help improve survival in this rapidly growing and underserved ethnic group. The proposed Hispanic/Latina Breast Cancer Survivorship Cohort Study will include approximately 4,110 women from three regions in the U.S. (California, Seattle-Puget Sound, and New Mexico) and will fill this extraordinary gap, as it will be the first of its kind to include a large survivorship cohort of women of Hispanic descent.

curriculum vitae maría elena martínez, m.p.h., ph.d

Documents